SpringerLink
Log in

Interferon-gamma and Tumour Necrosis Factor Production in Patients withHelicobacter pylori Infection

  • Published:
Irish Journal of Medical Science Aims and scope Submit manuscript

Abstract

The production of the cytokines, interferon-gamma and tumour necrosis factor by human antral mucosa cells and stimulated peripheral blood mononuclear cells were determined by enzyme linked immunosorbant assay and L929 bioassay respectively. Tumour necrosis factor production by peripheral blood mononuclear cells in response toHelicobacter pylori stimulation was depressed inHelicobacter pylori positive individuals, compared toHelicobacter pylori negative individuals (P < 0.05). There was no difference in tumour necrosis factor production by peripheral blood mononuclear cells in response to purified protein derivative. However, tumour necrosis factor production by cells isolated from gastric mucosa during short term culture was significantly higher inHelicobacter pylori positive patients (P < 0.05) than negative patients, indicating a probable macrophage response. Levels of interferon-gamma did not differ significantly in the gastric explant culture from the two groups. The results show thatHelicobacter pylori negative patients have a stronger peripheral cellular immune response toHelicobacter pylori infection. The higher levels of tumour necrosis factor production by antral mucosa cells inHelicobacter pylori positive patients may reflect the infiltration of T lymphocytes and macrophages within the local mucosa.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (France)

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Marshall, B.J. Unidentified curved bacilli on gastric epithelium in chronic gastritis. Lancet. 1983; 1: 1273–1275.

    Google Scholar 

  2. Goodwin, C. S., Armstrong, A. and Marshall, B.Campylobacter pylori gastritis and peptic ulcer. J. Clin. Microbiol. 1986; 39: 353–356.

    CAS  Google Scholar 

  3. Parsonnet, J., Friedman, G. D., Daniel, M. S., Vandersteen, P., Ghang, Y., Vogelman, J. H., Orentreich, D. E. E. N., Sibley, R. K.Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med. 1991; 325: 1127–31.

    PubMed  CAS  Google Scholar 

  4. Nomura, A., Stemmermann, G. N., Chyou, P. H., Kato, I., Perez-Perez, G. I., Blaser, M. J.Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N. Engl. J. Med. 1991; 325: 1132–36.

    PubMed  CAS  Google Scholar 

  5. Perez-perez, G. I., Workin, D. B., Chodos, M. J. E., Blaser, M. J.Campylobacter pylori antibodies in humans. Ann. Intern. Med. 1988; 109: 11–17.

    PubMed  CAS  Google Scholar 

  6. Karttunen, R., Anderssod, G., Poikonen, K., Kosunen, T. U., Karttunen, T., Juutinen, K., Niemela, S.Helicobacter pylori lymphocyte activation in peripheral blood cultures. Clin. Exp. Immunol. 1990; 82: 485–488.

    PubMed  CAS  Google Scholar 

  7. Crabtree, J. E., Rathbone, B. J., Heatley, R. V., Shallcross, T. M., Wyatt, J. I., Losowsky, M. S. Duodenal secretion ofCampylobacter pylori specific antibodiesin vitro. In: Megraud, F., Lamouliatte, J., eds. Gastroduodenal pathology andCampylobacter pylori. Amsterdam: Excerpta Medica, 1989; 341–4.

    Google Scholar 

  8. Rathbone, B. J., Wyatt, J. I., Worsley, B. W., Shires, S. E., Trejdosiewicz, L. K., Heatley, R. V., Losowsky, M. S. Systemic and local antibody responses to gastricCampylobacter pyloridis in non-ulcer dyspepsia. Gut 1986; 27: 642–7.

    Article  PubMed  CAS  Google Scholar 

  9. Paull, C. S., Armstrong, J. A., Marshall, B. J.Campylobacter pyloridis, gastric and peptic ulceration. J. Clin. Pathol. 1986; 39: 353–365.

    Article  Google Scholar 

  10. Paull, G., Yardley, J. Pathology ofCampylobacter pylori associated gastric and oesophageal lesions. InCampylobacter pylori in Gastritis and Peptic Ulcer Disease. M. J. Blaser, editor. Igaku-Shoin Medical Publishers, New York. 1989; 73–97.

    Google Scholar 

  11. Brenner, D. A., Buck, M., Feitelberg, S. P., Chojkier, M. Tumor Necrosis Factor-α inhibits albumin gene expression in a marine model of cachexia. J.Clin. Invest. 1990; 85: 248–255.

    Article  PubMed  CAS  Google Scholar 

  12. Tracey, Kevin J. and Helen Vlassara. Peptid Regulatory Factors. Cachectin/Tumour Necrosis Factor. Lancet. 1989; 20: 1122–27.

    Article  Google Scholar 

  13. O’Garra, Anne. Peptide Regulatory Factors. Interleukins and the immune system 2. Lancet. 1989; 6: 1003–1005.

    Article  Google Scholar 

  14. Le, J., Vilcek, J. Tumour necrosis factor and interleukin 1: cytokines with multiple overlap** biological activities. Lab Invest. 1987; 56: 234–8.

    PubMed  CAS  Google Scholar 

  15. Smith, K. A. T-cell growth factor. Immunol. Rev. 1980; 51: 337–357.

    Article  PubMed  CAS  Google Scholar 

  16. Frances, R. Balkwill. Peptide Regulatory Factors. Interferon. Lancet 1989; 13: 1060–1063.

    Google Scholar 

  17. Trinchieri, G., Perussia, B. Immune interferon: a pleiotropic lymphokine with multiple effects. Immunol Today. 1985; 6: 131–36.

    Article  CAS  Google Scholar 

  18. Westerberg, H., Gustafson, S. A., Nordenskjold, B., Silversward, C., Wallgren, A. Oestrogen receptor level and other factors in early recurrence of breast cancer. Int. J. Cancer. 1980; 26: 429–33.

    Article  PubMed  CAS  Google Scholar 

  19. Green, L. M, Reade, J. L., Ware, C.F. Rapid Colormetric Assay for Cell Viability: Application to the Quantitation of Cytotoxic and Growth Inhibitory Lymphokines. J. Immunol. Methods 1984; 70: 257–268.

    Article  PubMed  CAS  Google Scholar 

  20. Danis, V. A., Harries, A. D., Heatley, R. V.In vitro immunoglobulin secretion by normal human gastrointestinal mucosa tissues, and alterations in patients with inflammatory bowel disease. Clin. Exp. Immunol. 1984; 56: 159–166.

    PubMed  CAS  Google Scholar 

  21. Crabtree, J. E, Heatley, R. V., Losowsky, M. S. Glycoprotein synthesis and secretion by cultured small intestinal mucosa in calico disease. Gut 1989; 30: 1339–1343.

    Article  PubMed  CAS  Google Scholar 

  22. Peterson, G. L. A simplification of the protein assay method of Lowry et al which is more generally applicable. Anal. Biochem. 1987; 83: 346–56.

    Article  Google Scholar 

  23. Crabtree, J. E., Shallcross, T. M., Heatley, R. V., Wyatt, J. I. Mucosa tumour necrosis factor a and interleukin-6 in patients withHelicobacter pylori associated gastritis. Gut 1991; 32: 1473–77.

    Article  PubMed  CAS  Google Scholar 

  24. Meager, A. Antibodies against interferons: characterization of interferons and immunoassays. In: Clemens, M., Morris, A., Gearing, A., eds. Lymphokines and Interferons. IRL Press, Oxford 1987; 105–127.

    Google Scholar 

  25. Shahi, C. N., Fan, X. J., Chua, A., McDevitt, J., Weir, D. G., Keeling, P. W. N., Kelleher, D. Defective antigen-specific responses toHelicobacter pylori antigens in patients with gastricH. pylori colonisation. Gastroenterology 1992; 102: A694.

    Google Scholar 

  26. O’Garra, A. Peptide Regulatory Factors. Interleukins and the immune system 2. Lancet. 1989; 6: 1003–1005.

    Article  Google Scholar 

  27. Mai, U. E. H., Perez-Perez, G. I., Wahl, L. M., Wahl, S. M., Blaser, M. J., Smith, P. D. Soluble surface proteins fromHelicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism. J. Clin. Invest. 1991; 87: 894–900.

    Article  PubMed  CAS  Google Scholar 

  28. Strickland, R. G., Mackay, I. R. A reappraisal of the nature and significance of chronic atrophic gastritis. Am. J. Dig. Dis. 1973; 18: 426–440.

    Article  PubMed  CAS  Google Scholar 

  29. Greenlaw, R., Sheahan, D. G., Deluca, V., Melter, D. A., Myerson, D., Myerson, P. Gastroduodenitis: a broader concept of peptic ulcer disease. Dig. Dis. Sci. 1980; 25: 660–672.

    Article  PubMed  CAS  Google Scholar 

  30. Gilman, R. J., Leon-Barua, R., Koch, J. Rapid identification ofpylori Campylobacter in Peruvians with gastritis. Dig. Dis. Sic. 1986; 31: 1089–1094.

    Article  Google Scholar 

  31. Blaser, M.J. Gastric Campylobacter-like organisms, gastritis and peptic ulcer disease. Gastroenterol. 1987; 93: 371–383.

    CAS  Google Scholar 

  32. Karttunen, R. Blood lymphocyte proliferation, cytokine secretion and appearance of T cells with activation surface markers in cultures withHelicobacter pylori. Comparison of the responses of subjects with and without antibodies toH. pylori. Clin. Exp. Immunol. 1991; 83: 396–400.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Clinical Medicine and Gastroenterology, St. James’s Hospital, Trinity College Dublin, Ireland

    X. J. Fan, A. Chua, M. A. O’Connell, D. Kelleher & P. W. N. Keeling

Authors
  1. X. J. Fan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Chua
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. A. O’Connell
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. Kelleher
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P. W. N. Keeling
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fan, X.J., Chua, A., O’Connell, M.A. et al. Interferon-gamma and Tumour Necrosis Factor Production in Patients withHelicobacter pylori Infection. I.J.M.S. 162, 408–411 (1993). https://doi.org/10.1007/BF02996319

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02996319

Keywords

Search

Navigation